Your browser doesn't support javascript.
loading
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.
Do, Khanh; Cao, Liang; Kang, Zhigang; Turkbey, Baris; Lindenberg, Maria L; Larkins, Erin; Holkova, Beata; Steinberg, Seth M; Raffeld, Mark; Peer, Cody J; Figg, William D; Eugeni, Michelle; Jacobs, Paula; Choyke, Peter; Wright, John J; Doroshow, James H; Kummar, Shivaani.
Afiliación
  • Do K; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Cao L; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Kang Z; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Turkbey B; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Lindenberg ML; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Larkins E; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Holkova B; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Steinberg SM; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Raffeld M; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Peer CJ; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Figg WD; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Eugeni M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Jacobs P; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Choyke P; Center for Cancer Research, National Cancer Institute, Bethesda, MD.
  • Wright JJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD. Electronic address: kummars@mail.nih.gov.
Clin Colorectal Cancer ; 14(3): 154-61, 2015 Sep.
Article en En | MEDLINE | ID: mdl-25861837
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Receptores ErbB Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Colorectal Cancer Año: 2015 Tipo del documento: Article País de afiliación: Moldova
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas p21(ras) / Receptores ErbB Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Colorectal Cancer Año: 2015 Tipo del documento: Article País de afiliación: Moldova